SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000902664-23-001740
Filing Date
2023-02-14
Accepted
2023-02-14 10:27:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 ATHIRA PHARMA, INC. p23-0515sc13ga.htm SC 13G/A 62538
  Complete submission text file 0000902664-23-001740.txt   64210
Mailing Address 40 10TH AVENUE 7TH FLOOR NEW YORK NY 10014
Business Address 40 10TH AVENUE 7TH FLOOR NEW YORK NY 10014 646-597-6980
RTW INVESTMENTS, LP (Filed by) CIK: 0001493215 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011
Business Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011 (425) 620-8501
Athira Pharma, Inc. (Subject) CIK: 0001620463 (see all company filings)

IRS No.: 453368487 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91705 | Film No.: 23624083
SIC: 2836 Biological Products, (No Diagnostic Substances)